Application 206151
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ABACAVIR SULFATE AND LAMIVUDINE | ABACAVIR SULFATE; LAMIVUDINE | TABLET;ORAL | EQ 600MG BASE;300MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 35573-402 | Abacavir and Lamivudine | Abacavir and Lamivudine | Burel Pharma | ANDA | Current |
| 35573-402 | Abacavir and Lamivudine | Abacavir and Lamivudine | Burel Pharma | ANDA | Current |
| 35573-402 | Abacavir and Lamivudine | Abacavir and Lamivudine | Burel Pharmaceuticals, LLC | ANDA | Current |
| 35573-402 | Abacavir and Lamivudine | Abacavir and Lamivudine | Burel Pharma | ANDA | Current |
| 65862-900 | Abacavir and Lamivudine | Abacavir and Lamivudine | Aurobindo Pharma Limited | ANDA | Current |
| 65862-900 | Abacavir and Lamivudine | Abacavir and Lamivudine | Aurobindo Pharma Limited | ANDA | Current |
| 65862-900 | Abacavir and Lamivudine | Abacavir and Lamivudine | Aurobindo Pharma Limited | ANDA | Current |
| 65862-900 | Abacavir and Lamivudine | Abacavir and Lamivudine | Aurobindo Pharma Limited | ANDA | Current |
| 65862-900 | Abacavir and Lamivudine | Abacavir and Lamivudine | Aurobindo Pharma Limited | ANDA | Current |